Characterization of Leishmania donovani antigens encapsulated in liposomes that induce protective immunity in BALB/c mice
about
Possibilities and challenges for developing a successful vaccine for leishmaniasisPotentiating effects of MPL on DSPC bearing cationic liposomes promote recombinant GP63 vaccine efficacy: high immunogenicity and protectionLiposomes as nanomedical devicesTherapy with sodium stibogluconate in stearylamine-bearing liposomes confers cure against SSG-resistant Leishmania donovani in BALB/c miceLeishmania donovani: immunostimulatory cellular responses of membrane and soluble protein fractions of splenic amastigotes in cured patient and hamstersLeishmania donovani triose phosphate isomerase: a potential vaccine target against visceral leishmaniasisImmunogenicity and efficacy of single antigen Gp63, polytope and polytopeHSP70 DNA vaccines against visceral Leishmaniasis in experimental mouse modelEvaluation of Leishmania donovani protein disulfide isomerase as a potential immunogenic protein/vaccine candidate against visceral LeishmaniasisIdentification of novel Leishmania donovani antigens that help define correlates of vaccine-mediated protection in visceral leishmaniasisVisceral Leishmaniasis: Advancements in Vaccine Development via Classical and Molecular ApproachesTh1 stimulatory proteins of Leishmania donovani: comparative cellular and protective responses of rTriose phosphate isomerase, rProtein disulfide isomerase and rElongation factor-2 in combination with rHSP70 against visceral leishmaniasis.Isolation, characterization and antimicrobial evaluation of a novel compound N-octacosan 7β ol, from Fumaria parviflora Lam.Negatively charged liposomes show potent adjuvant activity when simply admixed with protein antigensApoptosis mediated leishmanicidal activity of Azadirachta indica bioactive fractions is accompanied by Th1 immunostimulatory potential and therapeutic cure in vivoCharacterization of immunoglobulin G and its subclass response to Indian kala-azar infection before and after chemotherapy.Comparison of in vivo Adjuvanticity of Liposomal PO CpG ODN with Liposomal PS CpG ODN: Soluble Leishmania Antigens as a Model.β-Nitrostyrenes as Potential Anti-leishmanial Agents.Sphingomyelin Liposomes Containing Soluble Leishmania major antigens Induced Strong Th2 Immune Response in BALB/c MiceLeishmaniasis: focus on the design of nanoparticulate vaccine delivery systems.Vaccine Development Against Leishmania donovani.Cationic liposomal vaccine adjuvants in animal challenge models: overview and current clinical status.Recent progress towards development of a Shigella vaccine.Delivery systems for Leishmania vaccine development.Proteoliposomes in nanobiotechnology.Immunological consequences of stress-related proteins--cytosolic tryparedoxin peroxidase and chaperonin TCP20--identified in splenic amastigotes of Leishmania donovani as Th1 stimulatory, in experimental visceral leishmaniasis.Nanobiotechnologic approach to a promising vaccine prototype for immunisation against leishmaniasis: a fast and effective method to incorporate GPI-anchored proteins of Leishmania amazonensis into liposomes.gp63 in stable cationic liposomes confers sustained vaccine immunity to susceptible BALB/c mice infected with Leishmania donovani.Combination therapy with paromomycin-associated stearylamine-bearing liposomes cures experimental visceral leishmaniasis through Th1-biased immunomodulationLiposomal formulations in the pharmacological treatment of leishmaniasis: a review.In vitro responses of human peripheral blood mononuclear cells to whole-cell, particulate and soluble extracts of Leishmania promastigotes.Biodistribution of liposome/DNA systems after subcutaneous and intraperitoneal inoculation.Identification of Potential MHC Class-II-Restricted Epitopes Derived from Leishmania donovani Antigens by Reverse Vaccinology and Evaluation of Their CD4+ T-Cell Responsiveness against Visceral Leishmaniasis.Leishmaniasis in humans: drug or vaccine therapy?PEGylation of cationic liposomes encapsulating soluble Leishmania antigens reduces the adjuvant efficacy of liposomes in murine model.Dermotropic Leishmania donovani in Sri Lanka: visceralizing potential in clinical and preclinical studies.Liposomal Elongation Factor-1α Triggers Effector CD4 and CD8 T Cells for Induction of Long-Lasting Protective Immunity against Visceral Leishmaniasis.Evaluation of an ELISA for canine leishmaniasis immunodiagnostic using recombinant proteins.Searching Genes Encoding Leishmania Antigens for Diagnosis and ProtectionThe potential HLA Class I-restricted epitopes derived from LeIF and TSA of Leishmania donovani evoke anti-leishmania CD8+ T lymphocyte response
P2860
Q26749758-F556AA70-5C1A-4855-949F-22B04C0DFF57Q27305883-7EEB0662-13FD-4885-BD48-B33DA3C6F1A1Q28088315-CA0A7772-3A73-4A26-BFBC-A03A588EAA61Q28477398-B5B880FB-5152-408C-8949-A31A5C6553A7Q28480398-0B129BBD-DA1D-409C-B270-9C411035F036Q28483976-5A0BD90B-B985-4FF3-8D0B-79F6BD22BC9BQ30940594-53D3748B-A0E6-431D-AC44-A23329D0A814Q31060208-C0C950D8-6C4D-4B21-8952-337E9B21ACDBQ33463435-D328CA8C-4716-489A-9A39-1A698C769F1DQ34076804-BB2EE1E1-7F96-446D-BDA3-3BC8E019E0E8Q34277331-1230AF91-65CA-4539-9427-67A58538E1C9Q35118485-F981BB08-4BD5-4D33-9305-7C8D16331AAFQ35141341-040C7F1F-84BF-41DB-8C92-F09141B3C96DQ35238066-2430B6E1-C0AC-4D5A-A6A6-2438FAE641C3Q35548955-1A4625E4-A698-4B51-AE3D-F14FFDC96103Q36652638-CD4B4DD6-F3D7-41E9-9F68-89DCD43094BFQ37224367-25F953DD-A83A-4971-880A-1DB58A5BD9FDQ37246219-E48BDA02-930C-4B09-809B-021B9D6EECEBQ37965724-C0062F7A-3134-4729-A727-A7CC85777B31Q38012112-98548DF0-C4D1-416A-9E14-8D14A9310B76Q38028994-143B0001-854F-4D2D-A232-1B8CA80DBD9DQ38068954-07A90701-115B-4EC4-BFE1-E7E1601B2C2EQ38746362-C9B1188C-F400-49F1-B541-022028E24F99Q39310225-F8BCA1AB-6383-46D7-A7F2-F19CC8C5CE4AQ41603970-F11C80D6-6A6C-4771-9889-72537BACC6ABQ41723457-5C8AE082-CFC9-437C-816B-67E4EE1FA412Q42002483-FC5CC2FE-D4C4-4BC8-A2AC-7C451758C1E3Q42706310-7B146EC6-36B5-4CFC-8FFE-847BA538EDD5Q43168913-7044A774-8EE6-4B6D-99D9-CD1C5B38542FQ45080997-7665F979-1BAF-4A6E-9429-10BE08461B3DQ45889122-4F7E2671-162F-4229-AE4A-8016A0411E3EQ47201994-113AED53-0292-4924-90E1-3A56C1979DABQ47556262-3CB63FC2-F447-4F15-B1E2-B930AACC57CBQ48332907-D7D327F7-5E1B-4722-8E68-2A62F77A1D41Q48347654-527028D5-7B54-410C-9ABF-81ED2C3062B3Q49210114-ECC34AD4-E171-4DA7-90BB-28A65F612C26Q52616476-6CD4EA77-2927-4E5D-A326-AC750A59D4CDQ58647150-3AEB0A99-E187-40F8-AA76-CA9F360F53DEQ58705894-20E77654-2D07-4E7F-978D-231BBB58C0DA
P2860
Characterization of Leishmania donovani antigens encapsulated in liposomes that induce protective immunity in BALB/c mice
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
Characterization of Leishmania ...... ective immunity in BALB/c mice
@en
Characterization of Leishmania ...... ctive immunity in BALB/c mice.
@nl
type
label
Characterization of Leishmania ...... ective immunity in BALB/c mice
@en
Characterization of Leishmania ...... ctive immunity in BALB/c mice.
@nl
prefLabel
Characterization of Leishmania ...... ective immunity in BALB/c mice
@en
Characterization of Leishmania ...... ctive immunity in BALB/c mice.
@nl
P2093
P2860
P1476
Characterization of Leishmania ...... ective immunity in BALB/c mice
@en
P2093
Farhat Afrin
Khairul Anam
Meenakshisundram Gopinath
Ravindran Rajesh
P2860
P304
P356
10.1128/IAI.70.12.6697-6706.2002
P407
P577
2002-12-01T00:00:00Z